Literature DB >> 1917039

Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination.

Y F Liaw1, S M Lin, I S Sheen, C M Chu.   

Abstract

Acute hepatitis C virus superinfection followed by spontaneous hepatitis B e antigen seroconversion and hepatitis B surface antigen clearance in a patient with chronic type B hepatitis is described. The observations suggests that HCV may exert a suppressive effect on hepatitis B virus.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1917039     DOI： 10.1007/bf01644957

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  14 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Hepatitis C virus infection in patients with nonalcoholic chronic liver disease.

Authors:  J M Sánchez-Tapias; J M Barrera; J Costa; M G Ercilla; A Parés; L Comalrrena; F Soley; J Bruix; X Calvet; M P Gil
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

3.  Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.

Authors:  Y F Liaw; C M Chu; I J Su; M J Huang; D Y Lin; C S Chang-Chien
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

4.  Treatment of chronic type B hepatitis in Southeast Asia.

Authors:  Y F Liaw; S M Lin; I S Sheen; T J Chen; C M Chu
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

5.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Influence of hepatitis delta virus superinfection on the clearance of hepatitis B virus (HBV) markers in HBV carriers in Japan.

Authors:  H Ichimura; I Tamura; T Tsubakio; O Kurimura; T Kurimura
Journal:  J Med Virol       Date:  1988-09       Impact factor: 2.327

7.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

8.  Simultaneous acute infections with hepatitis non-A, non-B, and B viruses.

Authors:  Y F Liaw; C M Chu; C S Chang-Chien; C S Wui
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

9.  Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections.

Authors:  D W Bradley; J E Maynard; K A McCaustland; B L Murphy; E H Cook; J W Ebert
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

10.  Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon.

Authors:  G L Davis; J H Hoofnagle; J G Waggoner
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327
View more
  16 in total

1.  Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.

Authors:  E Rodríguez-Iñigo; J Bartolomé; N Ortiz-Movilla; C Platero; J M López-Alcorocho; M Pardo; I Castillo; V Carreño
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

Review 3.  MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

Authors:  Kyoungsub Song; Chang Han; Srikanta Dash; Luis A Balart; Tong Wu
Journal:  World J Hepatol       Date:  2015-03-27

4.  Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

Authors:  L C Da Silva; C L Madruga; F J Carrilho; J R Pinho; A Saéz-Alquezar; C Santos; L Bassit; C Barreto; L E Fonseca; V A Alves; R Leitão; R Vianna; R A Cardoso; A V França; L C Gayotto
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

5.  Dual chronic hepatitis B virus and hepatitis C virus infection.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2009-08-08       Impact factor: 6.047

6.  Seroconversion of HBsAG coincides with hepatitis A super-infection: A case report.

Authors:  Claudia Beisel; Marylyn M Addo; Julian Schulze Zur Wiesch
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

7.  Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony.

Authors:  Shailaja Jamma; Ghazi Hussain; Daryl T-Y Lau
Journal:  Curr Hepat Rep       Date:  2010

8.  Viral replication in patients with concomitant hepatitis B and C virus infections.

Authors:  J Crespo; J L Lozano; B Carte; B de las Heras; F de la Cruz; F Pons-Romero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

9.  Effect of acute self-limited hepatitis C virus (HCV) superinfection on hepatitis B virus (HBV)-related cirrhosis. Virological features of HBV-HCV dual infection.

Authors:  Norio Akuta; Fumitaka Suzuki; Mariko Kobayashi; Akihito Tsubota; Yoshiyuki Suzuki; Tetsuya Hosaka; Takashi Someya; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

10.  Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.

Authors:  C T Yeh; C M Han; S Y Lo; J H Ou; K D Fan; I S Sheen; C M Chu; Y F Liaw
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.